Ajooni Biotech Secures ₹48 Million Order; Stock Gains Nearly 4%

New Delhi, September 17, 2025 – Ajooni Biotech Limited (NSE: AJOONI), a leading animal feed manufacturer, has announced receipt of a significant order worth ₹48 million from a valued customer. The order relates to the supply of scientifically formulated cattle feed to the customer. The order underlines the continued confidence of customers in its services and high-quality products. Following the announcement, the stock was trading at ₹5.85 per share (2.99% higher than the previous day’s close) at 12:45 PM.

Ajooni Biotech Limited, incorporated in 2010 and listed since May 2021, operates in the animal feed industry, supplying scientifically formulated cattle feed across India. The company has its works in Khanna, Punjab, and a registered office in Mohali.

Order Details

As per the regulatory details, the company did not disclose many details about the customer, as well as the duration of the order. The company emphasized that the deal underscores the trust in its product quality and services. This ₹48 million deal follows a recent ₹250 million contract with a leading dairy cooperative, highlighting sustained demand and aligning with Ajooni’s upcoming Punjab plant expansion to boost production capacity.

The company’s MD, Mr Jasjot Singh, stated that the company remains committed to delivering excellence, strengthening existing client relationships and creating sustainable value for all its customers.

Stock Performance

As of 12:45 PM, the stock was trading at ₹5.85 per share. It opened at ₹5.79 and the intraday low was ₹5.70 with the high being ₹5.94 during this session. After today’s surge, the stock has moved by 15.61% in the past month. The company’s market capitalisation now stands at ₹101.62 crore, with a free float market cap of ₹74.42 crore.

REF: https://nsearchives.nseindia.com/corporate/AJOONI_17092025105502_AJOONI__UpdateNSE_48_million_sd.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations